290 related articles for article (PubMed ID: 29403000)
1. The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.
Griebel G; Stemmelin J; Lopez-Grancha M; Fauchey V; Slowinski F; Pichat P; Dargazanli G; Abouabdellah A; Cohen C; Bergis OE
Sci Rep; 2018 Feb; 8(1):2416. PubMed ID: 29403000
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
3. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
[TBL] [Abstract][Full Text] [Related]
5. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
Zimmermann T; Bartsch JC; Beer A; Lomazzo E; Guggenhuber S; Lange MD; Bindila L; Pape HC; Lutz B
Neuropsychopharmacology; 2019 Jul; 44(8):1377-1388. PubMed ID: 30532004
[TBL] [Abstract][Full Text] [Related]
6. Amygdala FAAH and anandamide: mediating protection and recovery from stress.
Gunduz-Cinar O; Hill MN; McEwen BS; Holmes A
Trends Pharmacol Sci; 2013 Nov; 34(11):637-44. PubMed ID: 24325918
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
[TBL] [Abstract][Full Text] [Related]
10. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
[TBL] [Abstract][Full Text] [Related]
12. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Vázquez C; Tolón RM; Pazos MR; Moreno M; Koester EC; Cravatt BF; Hillard CJ; Romero J
Neurobiol Dis; 2015 Jul; 79():41-50. PubMed ID: 25917763
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats.
Carnevali L; Statello R; Vacondio F; Ferlenghi F; Spadoni G; Rivara S; Mor M; Sgoifo A
Eur Neuropsychopharmacol; 2020 Mar; 32():77-87. PubMed ID: 31948828
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
[TBL] [Abstract][Full Text] [Related]
19. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
Bisogno T; De Petrocellis L; Di Marzo V
Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
